Up About 25% This Year, Can Ulta Stock Keep Climbing?

Ulta Beauty reported robust Q2 2025 results, with net sales increasing 9.3% to $2.8 billion and comparable sales up 6.7%, prompting management to raise full-year sales and EPS guidance. While the stock has climbed 25% year-to-date and is now trading at approximately 23 times forward EPS, it is considered fairly valued given strong competition from Sephora and management's expressed caution regarding second-half consumer demand, suggesting limited immediate upside without further operational outperformance.

Analysis

Ulta Beauty delivered a strong Q2 2025, with net sales increasing 9.3% to $2.8 billion, driven by a 6.7% rise in comparable sales. The performance was broad-based, with growth across all major categories leading to market share gains. Profitability also improved, as gross margin expanded to 39.2% and EPS grew 9% to $5.78, prompting management to raise full-year guidance for sales to between $12.0 billion and $12.1 billion and EPS to a range of $23.85 to $24.30. The company's capital return strategy remains a significant tailwind, with $110 million in shares repurchased in the quarter and a substantial $2.2 billion authorization still available. However, following a 25% year-to-date stock appreciation, the valuation is now approximately 23 times forward earnings, which is considered fair. Key risks tempering the outlook include persistent competition from LVMH's Sephora, rising SG&A expenses, and management's own stated caution regarding consumer demand in the second half of the year. The current share price appears to fully reflect the positive operational momentum, suggesting limited upside without further outperformance on comps or margins.

Key Decisions for Investors

• Given the company's solid fundamentals and ongoing share repurchases, investors with existing positions may consider holding, as these factors provide a degree of support for the stock.
• Prospective investors should note the stock is trading near record highs at a fair valuation, and may want to await a pullback or a period of price consolidation before initiating a new position.
• Investors should closely monitor comparable sales figures and operating margins in subsequent quarters as a key indicator of whether the company can sustain its growth trajectory against heightened expectations and competitive pressure.